1. Home
  2. ADUS vs EVO Comparison

ADUS vs EVO Comparison

Compare ADUS & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Addus HomeCare Corporation

ADUS

Addus HomeCare Corporation

HOLD

Current Price

$113.08

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.93

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADUS
EVO
Founded
1979
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.1B
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
ADUS
EVO
Price
$113.08
$2.93
Analyst Decision
Buy
Strong Buy
Analyst Count
11
1
Target Price
$138.73
$7.00
AVG Volume (30 Days)
174.5K
238.0K
Earning Date
11-03-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
6.76
N/A
EPS
4.66
N/A
Revenue
$1,346,596,000.00
$887,396,457.00
Revenue This Year
$25.50
N/A
Revenue Next Year
$7.11
$8.80
P/E Ratio
$24.21
N/A
Revenue Growth
18.77
N/A
52 Week Low
$88.96
$2.84
52 Week High
$136.72
$5.10

Technical Indicators

Market Signals
Indicator
ADUS
EVO
Relative Strength Index (RSI) 46.29 38.55
Support Level $110.07 $2.94
Resistance Level $116.00 $3.05
Average True Range (ATR) 2.92 0.10
MACD -0.27 0.01
Stochastic Oscillator 26.27 18.67

Price Performance

Historical Comparison
ADUS
EVO

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, mainly to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are medical in nature to those individuals who may require assistance during an illness or after surgery.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: